← Back
$IRD All transactions

Opus Genetics, Inc.

C

$ Value

Shares

6,927,419

Price

Filed

May 6

Insider

Name

Foundation Fighting Blindness Retinal Degeneration Fund

Title

CIK

0002042266

Roles

Director 10% Owner Other

Transaction Details

Transaction Date

2025-05-05

Code

C

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

9,492,171

Footnotes

Each share of Series A non-voting convertible preferred stock (the "Preferred Stock") automatically converted into 1,000 shares of the Issuer's common stock as of 5:00 p.m. Eastern time on the third business day after the date that the Issuer's stockholders approved the conversion of the Preferred Stock into shares of the Issuer's common stock, which approval occurred on April 30, 2025. | Foundation Fighting Blindness, Inc. ("FFB") is the sole member of Foundation Fighting Blindness Retinal Degeneration Fund ("RDF") and may be deemed to beneficially own the securities owned directly by RDF. RDF has the power to vote and dispose of any securities directly owned by RDF. RDF's board of directors makes voting and investment decisions regarding securities held by RDF, subject to certain approval rights of the board of directors of FFB with respect to transactions exceeding a certain threshold. | The shares of Preferred Stock were issued to the Reporting Persons in connection with a merger and reorganization in a stock-for-stock transaction.

Filing Info

Accession No.

0001578563-25-000238

Form Type

4

Issuer CIK

0001228627

Foundation Fighting Blindness Retinal Degeneration Fund's History

Date Ticker Type Value
2025-12-09 IRD $8.6M
2025-05-05 IRD C
2025-05-05 IRD C

Other Insiders at IRD (90d)

Insider Bought Sold Last
YERXA BENJAMIN R
President
2026-01-22
SCHACHLE JOSEPH K
Chief Operating Officer
$20K 2026-03-16
MANUSO JAMES S J 2026-04-20
Rodgers Richard J 2026-04-20
Graves Adrienne L 2026-04-20
Benton Susan 2026-04-20
Gagnon Robert E.
Chief Financial Officer
2026-01-22
Gallagher Cam 2026-04-20
Ainsworth Sean 2026-04-20
Zaremba Rabourn Amy
Head of Fin. Quality Assurance
$15K 2026-03-16
Bennett Jean 2026-04-20
Magrath George
Chief Executive Officer
$127K 2026-03-16
Jayagopal Ashwath
Chief Scientific & Dev. Ofc.
$19K 2026-03-16